|
Ulrich Pessara is a partner based in our Munich office. With more than 20 years experience, Dr. Pessara combines unique expertise as a scientist with extensive business, operational and financial experience in the pharmaceutical and biotech industries.
Experience
Prior to joining JSB-Partners, Dr. Pessara was a co-founder and Chief Development Officer of Xantos Biomedicine, a Munich-based biotech company, where he was responsible for business development and strategic development. Previously, he was a director of program management for international biotechnology alliances at F. Hoffmann-La Roche. During that time, he served as a managing director and board member in several international joint venture biotech companies based variously in San Diego, CA, Milan, Italy and Hanover, Germany. Before Roche, Dr. Pessara was with Boehringer Mannheim, where he was responsible for biopharmaceutical drug development. Prior to joining the pharmaceutical and biotechnology industries, Dr. Pessara had an active academic career in molecular immunology.
Boards
Dr. Pessara is a member of the Investment Committee of the State Bank of Saxony, Germany and a member of the board of directors of JADO Technologies GmbH and Novoplant GmbH. He has served on the scientific advisory boards of the Cell Therapy Center, Germany, and Molecular Medicine LLC, in San Diego, CA.
Education
Dr. Pessara earned a BS at the University of Cologne, Germany, a PhD at the German Cancer Research Center in Heidelberg, Germany and held a postdoctoral position at the University of Strasbourg, France. | 